plicamycin has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JC; Fan, K; Nghiem, P; Paulson, KG; Ritter, C; Schrama, D | 1 |
| Ratajewski, M; Sachrajda, I | 1 |
2 other study(ies) available for plicamycin and Cancer of Skin
| Article | Year |
|---|---|
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Topics: Acetylation; Animals; Carcinoma, Merkel Cell; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Silencing; Histocompatibility Antigens Class I; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Killer Cells, Lymphokine-Activated; Mice; Mice, Inbred NOD; NK Cell Lectin-Like Receptor Subfamily K; Plicamycin; Promoter Regions, Genetic; Signal Transduction; Skin Neoplasms; Vorinostat; Xenograft Model Antitumor Assays | 2016 |
Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8.
Topics: ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Plicamycin; Promoter Regions, Genetic; Skin Neoplasms; Sp1 Transcription Factor | 2011 |